Clinical Validation

A 200 patient clinical trial based on Barrett's surveillance for oesophageal cancer has already been completed, with excellent results. The diagnostic algorithm was able to identify healthy and benign oesophageal biopsies with up to 99% specificity; meaning healthy diagnoses are given with certainty. Reducing the bulk of healthy samples that have to be sent for more complex and time-consuming analyses would generate significant time and cost savings.

To find out more please contact us.